(Q38127467)

29 August 2017

title

Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome (English)

1 reference

29 August 2017

0 references

1 reference

Debraj Guhathakurta

1

1 reference

29 August 2017

Nadeem A Sheikh

2

1 reference

29 August 2017

T Craig Meagher

3

1 reference

29 August 2017

Simon Letarte

4

1 reference

29 August 2017

James B Trager

5

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

Expert Review of Clinical Pharmacology

29 August 2017

published in

1 reference

29 August 2017

volume

6

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

387-401

1 reference

Systems biology and new technologies enable predictive and preventative medicine.

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

A systems biology approach to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

A decade of systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Systems biology in immunology: a computational modeling perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

How molecular profiling could revolutionize drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Unveiling the role of network and systems biology in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Unraveling human complexity and disease with systems biology and personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

FDA perspectives on potential microarray-based clinical diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Systems vaccinology: learning to compute the behavior of vaccine induced immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

A genomic approach to human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Immunotherapy of cancer in 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Inflammation and immune surveillance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Assessing the human immune system through blood transcriptomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Proteomics by mass spectrometry: approaches, advances, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Protein microarrays: high-throughput tools for proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Antibody array analysis of labelled proteomes: how should we control specificity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Sequencing technologies - the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

RNA sequencing: advances, challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

The identification of human tumour antigens: Current status and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Cancer/testis (CT) antigens: potential targets for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Identifying potential tumor markers and antigens by database mining and rapid expression screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Identification of cancer/testis genes by database mining and mRNA expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Seromic profiling of ovarian and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Exploiting the mutanome for tumor vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Identification of tumour antigens by serological analysis of cDNA expression cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Predicting peptide binding to Major Histocompatibility Complex molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Identification of breast cancer peptide epitopes presented by HLA-A*0201.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

An integrated genome-wide approach to discover tumor-specific antigens as potential immunologic and clinical targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Targeting the tumor mutanome for personalized vaccination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Transcriptional control of the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Integrating genomic signatures for immunologic discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Memory T cells have gene expression patterns intermediate between naive and effector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Transcriptional insights into the CD8(+) T cell response to infection and memory T cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Gene set enrichment analysis: performance evaluation and usage guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

PAGED: a pathway and gene-set enrichment database to enable molecular phenotype discoveries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

GeneSigDB: a manually curated database and resource for analysis of gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Gene ontology: tool for the unification of biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

KEGG for integration and interpretation of large-scale molecular data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Reactome: a database of reactions, pathways and biological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

NCBI GEO: archive for functional genomics data sets--10 years on

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Gene set enrichment analysis made simple

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Cancer immunotherapy via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Transcriptional profiling of vaccine-induced immune responses in humans and non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Transcriptomes of the B and T lineages compared by multiplatform microarray profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

High-throughput gene expression profiling of memory differentiation in primary human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Cell type-specific gene expression differences in complex tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Determinant spreading and tumor responses after peptide-based cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Epitope spreading in immune-mediated diseases: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

A viral vaccine encoding prostate-specific antigen induces antigen spreading to a common set of self-proteins in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Exome sequencing as a tool for Mendelian disease gene discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Genome structural variation discovery and genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Advances in understanding cancer genomes through second-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Statistical inference of the generation probability of T-cell receptors from sequence repertoires

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Wrestling with the repertoire: the promise and perils of next generation sequencing for antigen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Next generation sequencing for TCR repertoire profiling: platform-specific features and correction algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Immunologic biomarkers as correlates of clinical response to cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Promise and pitfalls of the Immunochip

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Genetics of human gene expression: mapping DNA variants that influence gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Mapping the genetic architecture of gene expression in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Defining the critical hurdles in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Improved endpoints for cancer immunotherapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Therapeutic cancer vaccines in prostate cancer: the paradox of improved survival without changes in time to progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Direct multiplexed measurement of gene expression with color-coded probe pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Addressing the problems with life-science databases for traditional uses and systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Data management: it starts at the bench

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

The road we must take: multidisciplinary team science

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

A data integration methodology for systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

NEW: network-enabled wisdom in biology, medicine, and health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

An immune-active tumor microenvironment favors clinical response to ipilimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17512433.2013.811814

10.1586/17512433.2013.811814

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference